Best practices: Appropriate use of the new β-lactam/β-lactamase inhibitor combinations, ceftazidime-avibactam and ceftolozane-tazobactam in South Africa
暂无分享，去创建一个
M. Mendelson | C. Feldman | O. Perovic | A. Brink | G. Richards | N. Schellack | W. Lowman | C. Govind | S. Wasserman | J. Coetzee | Abraham J. Niehaus | M. Miller | H. Tootla | Malcolm G A Miller